CD274 and non-small cell lung carcinoma: PD-L1 inhibitors have been shown to be helpful in treating various types of cancer including metastatic melanoma, non-small cell lung cancer, and gastrointestinal cancer (Alsaab et al., 2017; Sharma and Allison, 2015).